Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology.

Kosumi K, Mima K, Baba H, Ogino S.

J Lab Precis Med. 2018 Sep;3. pii: 76. doi: 10.21037/jlpm.2018.09.05. Epub 2018 Sep 25. No abstract available.

2.

The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.

Stecher B.

Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.

PMID:
26185088
3.

Gut microbiota imbalance and colorectal cancer.

Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M.

World J Gastroenterol. 2016 Jan 14;22(2):501-18. doi: 10.3748/wjg.v22.i2.501. Review.

4.

Role of gut microbiota in the pathogenesis of colorectal cancer; a review article.

Jahani-Sherafat S, Alebouyeh M, Moghim S, Ahmadi Amoli H, Ghasemian-Safaei H.

Gastroenterol Hepatol Bed Bench. 2018 Spring;11(2):101-109. Review.

5.

[Gut microbiota: What impact on colorectal carcinogenesis and treatment?]

Bruneau A, Baylatry MT, Joly AC, Sokol H.

Bull Cancer. 2018 Jan;105(1):70-80. doi: 10.1016/j.bulcan.2017.10.025. Epub 2017 Dec 6. Review. French.

PMID:
29217301
6.

Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.

Kang M, Martin A.

Semin Immunol. 2017 Aug;32:3-13. doi: 10.1016/j.smim.2017.04.003. Epub 2017 May 2. Review.

PMID:
28465070
7.

Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke.

Singh V, Roth S, Llovera G, Sadler R, Garzetti D, Stecher B, Dichgans M, Liesz A.

J Neurosci. 2016 Jul 13;36(28):7428-40. doi: 10.1523/JNEUROSCI.1114-16.2016.

8.

Microbial Interactions and Interventions in Colorectal Cancer.

Van Raay T, Allen-Vercoe E.

Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.BAD-0004-2016. Review.

PMID:
28643625
9.

Gut microbiota and colorectal cancer.

Gao R, Gao Z, Huang L, Qin H.

Eur J Clin Microbiol Infect Dis. 2017 May;36(5):757-769. doi: 10.1007/s10096-016-2881-8. Epub 2017 Jan 7. Review.

10.

Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.

Tomasello G, Tralongo P, Damiani P, Sinagra E, Di Trapani B, Zeenny MN, Hussein IH, Jurjus A, Leone A.

World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121. Review.

11.

Gut microbiome and colorectal adenomas.

Dulal S, Keku TO.

Cancer J. 2014 May-Jun;20(3):225-31. doi: 10.1097/PPO.0000000000000050. Review.

12.

Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases.

Tomasello G, Mazzola M, Leone A, Sinagra E, Zummo G, Farina F, Damiani P, Cappello F, Gerges Geagea A, Jurjus A, Bou Assi T, Messina M, Carini F.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):461-466. doi: 10.5507/bp.2016.052. Epub 2016 Oct 26. Review.

13.

Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.

Chen YX, Lai LN, Zhang HY, Bi YH, Meng L, Li XJ, Tian XX, Wang LM, Fan YM, Zhao ZF, Han DW, Ji C.

World J Gastroenterol. 2016 Mar 14;22(10):2949-59. doi: 10.3748/wjg.v22.i10.2949.

14.

Dysbiosis of gut microbiota in promoting the development of colorectal cancer.

Zou S, Fang L, Lee MH.

Gastroenterol Rep (Oxf). 2018 Feb;6(1):1-12. doi: 10.1093/gastro/gox031. Epub 2017 Oct 11. Review.

15.

Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.

Putignani L, Del Chierico F, Vernocchi P, Cicala M, Cucchiara S, Dallapiccola B; Dysbiotrack Study Group.

Inflamm Bowel Dis. 2016 Feb;22(2):487-504. doi: 10.1097/MIB.0000000000000602. Review.

PMID:
26588090
16.

Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Peterson CT, Sharma V, Elmén L, Peterson SN.

Clin Exp Immunol. 2015 Mar;179(3):363-77. doi: 10.1111/cei.12474. Review.

17.

Gut microbiota and colorectal cancer.

Yamamoto M, Matsumoto S.

Genes Environ. 2016 Jun 1;38:11. doi: 10.1186/s41021-016-0038-8. eCollection 2016. Review.

18.

Dysbiosis signature of fecal microbiota in colorectal cancer patients.

Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, Chen Y, Yang F, Lu N, Wang Z, Luan C, Liu Y, Wang B, Xiang C, Wang Y, Zhao F, Gao GF, Wang S, Li L, Zhang H, Zhu B.

Microb Ecol. 2013 Aug;66(2):462-70. doi: 10.1007/s00248-013-0245-9. Epub 2013 Jun 4.

PMID:
23733170
19.

Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.

Higashimura Y, Naito Y, Takagi T, Uchiyama K, Mizushima K, Ushiroda C, Ohnogi H, Kudo Y, Yasui M, Inui S, Hisada T, Honda A, Matsuzaki Y, Yoshikawa T.

Am J Physiol Gastrointest Liver Physiol. 2016 Mar 15;310(6):G367-75. doi: 10.1152/ajpgi.00324.2015. Epub 2016 Jan 14.

20.

Gut microbiota: next frontier in understanding human health and development of biotherapeutics.

Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C.

Biologics. 2011;5:71-86. doi: 10.2147/BTT.S19099. Epub 2011 Jul 11.

Supplemental Content

Support Center